Clinical Approach to Ptosis

Comprehensive Practical Framework

1
Symptom Overview
Overview
2
Pathophysiology
Mechanism
3
History Taking
History
4
Physical Examination
Examination
5
Differential Diagnosis
Differential
6
Investigations
Workup
7
Clinical Decision-Making
Algorithm
8
Pearls and Pitfalls
Summary

1. Symptom Overview

Understanding the clinical significance and classification of ptosis

Ptosis, or drooping of the upper eyelid, is a common presenting complaint in neurology clinics, affecting approximately 4-6% of adults. While often benign and age-related, ptosis can be the first manifestation of serious neurological conditions including myasthenia gravis, Horner syndrome, or third cranial nerve palsy. The ability to systematically evaluate ptosis is essential, as missed diagnoses can have significant consequences—from life-threatening aneurysms to treatable autoimmune conditions.

Definition

Ptosis (from Greek “ptōsis” meaning falling) is defined as abnormal drooping of the upper eyelid with the eye in primary gaze. Normal upper eyelid position covers 1-2 mm of the superior cornea. Ptosis is clinically significant when the margin reflex distance 1 (MRD1)—the distance from the corneal light reflex to the upper eyelid margin—is less than 2 mm (normal: 4-5 mm), or when there is asymmetry greater than 2 mm between the two eyes.

Key Epidemiology

Prevalence: Acquired ptosis affects approximately 4-6% of adults, increasing with age
Age-related (aponeurotic) ptosis: Most common cause in adults over 60, affecting up to 15% of the elderly population
Myasthenia gravis: Ptosis is the presenting symptom in 50-70% of patients
Third nerve palsy: Accounts for approximately 25% of acquired oculomotor palsies in adults

Classification by Onset and Duration

Category	Duration	Common Causes	Clinical Significance
Acute	Hours to days	Third nerve palsy (aneurysm, ischemia), myasthenic crisis, trauma, botulism	Requires urgent evaluation; posterior communicating artery aneurysm is a neurosurgical emergency
Subacute	Days to weeks	Myasthenia gravis, inflammatory conditions, Horner syndrome (malignancy workup needed)	Warrants expedited workup; may indicate underlying systemic disease
Chronic	Months to years	Aponeurotic (age-related), chronic progressive external ophthalmoplegia, congenital	Often benign but may mask slowly progressive neuromuscular disease

Classification by Etiology

Neurogenic Ptosis

Mechanism: Disruption of neural pathways to eyelid elevators

Key types: Third cranial nerve palsy, Horner syndrome, Marcus Gunn jaw-winking

Clinical clue: Often associated with other neurological deficits (pupil abnormalities, diplopia)

Myogenic Ptosis

Mechanism: Primary muscle disease or neuromuscular junction dysfunction

Key types: Myasthenia gravis, myotonic dystrophy, chronic progressive external ophthalmoplegia

Clinical clue: Fatigability, bilateral involvement, associated muscle weakness

Aponeurotic Ptosis

Mechanism: Dehiscence or stretching of the levator aponeurosis

Key types: Involutional (age-related), post-surgical, contact lens-related

Clinical clue: High lid crease, good levator function, often bilateral

Mechanical Ptosis

Mechanism: Physical weighing down or restriction of the eyelid

Key types: Lid tumors, dermatochalasis, blepharochalasis, orbital masses

Clinical clue: Visible mass or excess tissue, proptosis may be present

Classification by Laterality

Pattern	Description	Suggests
Unilateral with pupil involvement	Ptosis with dilated, fixed pupil	Third nerve palsy (compressive—aneurysm until proven otherwise)
Unilateral with miosis	Ptosis with small pupil, often mild (1-2 mm)	Horner syndrome (sympathetic pathway lesion)
Unilateral with normal pupil	Isolated ptosis without pupil abnormality	Aponeurotic, myasthenia gravis, partial third nerve palsy
Bilateral symmetric	Equal drooping both sides	Myopathy, bilateral aponeurotic, chronic progressive external ophthalmoplegia
Bilateral asymmetric	Both sides affected but unequal	Myasthenia gravis (classic presentation), bilateral aponeurotic
Variable/fluctuating	Changes throughout the day or with fatigue	Myasthenia gravis (hallmark feature)

The Three Critical Questions: When evaluating any patient with ptosis, systematically answer these three questions:

Is the pupil involved? — A dilated pupil with ptosis is a third nerve palsy and potential aneurysm until proven otherwise
Is there fatigability? — Ptosis that worsens with sustained upgaze strongly suggests myasthenia gravis
Are there associated neurological signs? — Diplopia, facial weakness, or limb weakness points toward neurological etiology

Severity Grading

Grade	MRD1 Measurement	Clinical Description	Functional Impact
Mild	2-3 mm	Upper lid covers 2-3 mm of superior cornea	Cosmetic concern; minimal visual impact
Moderate	0-2 mm	Upper lid covers superior pupil margin	May affect superior visual field; compensatory head tilt
Severe	Less than 0 mm (negative)	Upper lid covers visual axis	Significant visual field obstruction; amblyopia risk in children

2. Pathophysiology and Mechanisms

Understanding the anatomical and physiological basis of ptosis

The upper eyelid is elevated by two muscles working in concert: the levator palpebrae superioris (the primary elevator, striated muscle under voluntary control) and Müller’s muscle (a smooth muscle providing sympathetic tone). Understanding the innervation and function of these structures is essential for localizing the cause of ptosis and guiding appropriate investigation.

Anatomy of Eyelid Elevation

Structure	Type	Innervation	Function	Contribution
Levator palpebrae superioris	Striated (voluntary)	Superior division of oculomotor nerve (cranial nerve III)	Primary eyelid elevation	Elevates lid 12-15 mm
Müller’s muscle (superior tarsal muscle)	Smooth (involuntary)	Sympathetic fibers (from superior cervical ganglion)	Maintains eyelid tone, fine-tunes position	Elevates lid 2-3 mm
Frontalis muscle	Striated (voluntary)	Facial nerve (cranial nerve VII)	Compensatory brow elevation	Accessory elevator (recruited in ptosis)
Levator aponeurosis	Connective tissue	Not applicable	Transmits levator force to tarsal plate	Creates lid crease; dehiscence causes ptosis

Neural Pathways Controlling Eyelid Position

Oculomotor Nerve (Cranial Nerve III) Pathway

Level	Structure	Clinical Correlate
Nuclear	Oculomotor nucleus in midbrain (single central caudal nucleus for both levators)	Nuclear lesions cause bilateral ptosis; associated with other third nerve findings
Fascicular	Nerve fibers passing through midbrain	May have crossed cerebellar signs (Nothnagel syndrome) or red nucleus involvement (Benedikt syndrome)
Subarachnoid	Nerve courses between posterior cerebral and superior cerebellar arteries, past posterior communicating artery	Aneurysm compression: pupil-involving third nerve palsy is classic
Cavernous sinus	Nerve runs in lateral wall of cavernous sinus	May be associated with other cranial neuropathies (IV, V1, V2, VI); often painful
Orbital	Superior division enters orbit through superior orbital fissure	May have isolated superior division palsy (ptosis + limited upgaze, sparing pupil)

Sympathetic Pathway (Horner Syndrome)

Order	Pathway	Lesion Location	Associated Features
First-order (central)	Hypothalamus → ciliospinal center of Budge (C8-T2)	Brainstem stroke, demyelination, tumor	Ipsilateral weakness, sensory loss, ataxia (Wallenberg syndrome if lateral medullary)
Second-order (preganglionic)	Ciliospinal center → superior cervical ganglion (over lung apex)	Pancoast tumor, cervical rib, thyroid surgery, trauma	May have arm pain, hand weakness (lower brachial plexus involvement)
Third-order (postganglionic)	Superior cervical ganglion → along internal carotid artery → orbit	Carotid dissection, cavernous sinus lesion, cluster headache	Facial pain, neck pain, carotidynia; isolated Horner if postganglionic

How Conditions Cause Ptosis

Condition	Mechanism	Key Features	Treatment Implication
Third nerve palsy (compressive)	Compression of superficial pupillomotor fibers → pupil dilation; levator denervation → ptosis	Pupil-involving, complete ptosis, “down and out” eye	Neurosurgical emergency if aneurysm; urgent imaging required
Third nerve palsy (ischemic)	Microvascular ischemia affects central nerve fibers; pupil often spared	Pupil-sparing, painful, often diabetic patients	Risk factor modification; usually recovers in 3 months
Horner syndrome	Loss of sympathetic innervation to Müller’s muscle → 1-2 mm ptosis; pupillary dilator affected → miosis	Mild ptosis, miosis, +/- anhidrosis	Must localize lesion; imaging to exclude malignancy (Pancoast tumor, carotid dissection)
Myasthenia gravis	Antibodies against acetylcholine receptors → impaired neuromuscular transmission → fatigable weakness	Fatigable ptosis, worse with sustained upgaze, variable throughout day	Acetylcholinesterase inhibitors; immunotherapy; thymectomy consideration
Aponeurotic (involutional) ptosis	Dehiscence or stretching of levator aponeurosis from tarsal plate	High or absent lid crease, good levator function, elderly patients	Surgical repair (levator advancement or Müller’s muscle resection)
Chronic progressive external ophthalmoplegia	Mitochondrial myopathy affecting extraocular muscles and levator	Bilateral, symmetric, slowly progressive; ophthalmoplegia without diplopia	Supportive care; screen for systemic mitochondrial disease (Kearns-Sayre syndrome)
Myotonic dystrophy	Abnormal chloride channel function → myotonia and progressive muscle wasting	Bilateral ptosis, facial weakness (“hatchet face”), grip myotonia	Multisystem surveillance; genetic counseling; supportive treatment

The Pupil Paradox in Ptosis

The pupil provides crucial localizing information in ptosis:

Dilated pupil + ptosis = Third nerve palsy (pupillomotor fibers on nerve surface are compressed first by aneurysm)
Constricted pupil + ptosis = Horner syndrome (loss of sympathetic pupillodilation)
Normal pupil + ptosis = Myasthenia gravis, aponeurotic, or partial/ischemic third nerve palsy

Remember: An ischemic third nerve palsy typically spares the pupil because the superficial pupillomotor fibers have a separate blood supply and are resistant to ischemia, while compression (aneurysm) affects the surface fibers first.

The Fatigability Phenomenon in Myasthenia Gravis

Normal Neuromuscular Transmission

Acetylcholine (ACh) released from motor nerve terminal
ACh binds to nicotinic receptors on muscle endplate
Abundant “safety factor”—more receptors than needed
Repeated stimulation maintains muscle contraction

Myasthenia Gravis

Antibodies reduce functional ACh receptors
Reduced safety factor for transmission
Initial contractions may be normal
Repeated stimulation depletes available receptors → fatigue
Rest allows receptor recovery → improvement

Why Ptosis is Common in Myasthenia Gravis: The levator palpebrae superioris is particularly vulnerable to myasthenic weakness because:

It must contract continuously throughout waking hours (no rest periods)
It has a unique fiber composition with fewer motor units
Extraocular muscles have fewer ACh receptors per endplate than limb muscles
The eyes are exposed to temperature variations that may affect neuromuscular transmission

Compensatory Mechanisms

Mechanism	Clinical Sign	Significance
Frontalis overaction	Raised eyebrow, forehead wrinkles	Suggests chronic ptosis; patient using frontalis to elevate lid
Chin-up head posture	Extended neck, backward head tilt	Attempts to see under drooping lid; may cause neck pain
Contralateral lid retraction	Opposite eyelid appears wide open	Hering’s law—increased innervation to ptotic levator spreads to normal side; manual elevation of ptotic lid unmasks contralateral ptosis

Hering’s Law and “Unmasking” Ptosis

According to Hering’s law of equal innervation, both levator muscles receive equal neural input. In unilateral ptosis, the brain increases drive to both levators to lift the affected lid. This causes the normal lid to retract (appear wide open). When examining a patient with apparently unilateral ptosis, manually elevate the ptotic lid and observe the contralateral lid—it may drop, “unmasking” bilateral ptosis. This is critical before surgical planning to avoid postoperative ptosis of the contralateral eye.

3. History Taking

A comprehensive approach to eliciting the ptosis history

Red Flags — Require Urgent Evaluation

Acute onset with headache — Posterior communicating artery aneurysm
Dilated, fixed pupil — Compressive third nerve palsy (aneurysm)
Diplopia with ptosis — Third nerve palsy, myasthenia gravis
Associated neck or facial pain — Carotid dissection (Horner syndrome)

Rapidly progressive weakness — Myasthenic crisis, botulism
Dysphagia or dysarthria — Bulbar myasthenia, brainstem lesion
Respiratory difficulty — Myasthenic crisis (impending respiratory failure)
Recent trauma — Traumatic third nerve palsy, orbital injury

Systematic History: The “DROOP” Approach

Use the mnemonic “DROOP” to ensure comprehensive history taking for ptosis:

D — Duration and onset: When did you first notice the drooping? Was it sudden or gradual? Has it progressed?
R — Right, left, or both: Which eye is affected? Has it switched sides? Is it symmetric?
O — Other symptoms: Any double vision? Difficulty swallowing or speaking? Weakness elsewhere? Headache or pain?
O — Oscillation and fatigue: Does it vary throughout the day? Worse in the evening? Better after rest? Worse with reading or sustained upgaze?
P — Pupil and past history: Have you noticed any change in pupil size? Any previous episodes? Family history of similar problems?

Targeted Questions by Suspected Cause

Suspected Cause	Key Features	Ask This Question
Third nerve palsy (aneurysm)	Acute onset, severe headache, pupil involvement	“Did you have a sudden severe headache when this started? Is this the worst headache of your life?”
Third nerve palsy (ischemic)	Diabetic, hypertensive, painful, pupil-sparing	“Do you have diabetes or high blood pressure? Is there pain around or behind the eye?”
Horner syndrome	Mild ptosis, small pupil, neck/arm symptoms	“Have you had any neck pain or trauma? Any arm pain or weakness? Any recent surgeries on your neck or chest?”
Myasthenia gravis	Fatigability, variability, bilateral asymmetric	“Is the drooping worse at the end of the day or when you’re tired? Does it improve after rest or sleep?”
Myasthenia gravis (bulbar)	Dysarthria, dysphagia, nasal voice	“Do you have trouble swallowing or chewing? Does your voice become slurred or nasal as the day goes on?”
Aponeurotic (age-related) ptosis	Gradual onset, elderly, contact lens use, prior surgery	“Has this been developing slowly over months or years? Do you wear contact lenses? Have you had any eye surgery?”
Chronic progressive external ophthalmoplegia	Bilateral, symmetric, slowly progressive, no diplopia	“Has anyone mentioned you have difficulty moving your eyes? Do you have double vision? Any muscle weakness or exercise intolerance?”
Myotonic dystrophy	Bilateral ptosis, facial weakness, myotonia, family history	“Do you have difficulty releasing your grip after shaking hands? Does anyone in your family have similar facial features or muscle problems?”
Carotid dissection	Horner syndrome with neck/face pain, recent trauma	“Have you had any neck manipulation, chiropractic treatment, or trauma recently? Any sudden neck or face pain?”
Orbital or eyelid mass	Progressive, proptosis, mechanical limitation	“Have you noticed your eye appearing more prominent? Any swelling or lumps around the eye?”

Assessing Timing and Variability

Pattern	Description	Suggests
Worse in evening	Ptosis minimal in morning, progressive worsening through day	Myasthenia gravis (classic pattern)
Better after rest	Improves after nap or closing eyes for several minutes	Myasthenia gravis
Constant throughout day	No significant fluctuation	Aponeurotic, third nerve palsy, Horner syndrome
Variable side to side	Alternates between eyes or changes in asymmetry	Highly suggestive of myasthenia gravis
Worse with reading	Worsens with prolonged reading or computer use	Myasthenia gravis (sustained upgaze fatigues levator)

Medication and Past Medical History

Medications That Can Cause or Worsen Ptosis

Botulinum toxin injections — Cosmetic or therapeutic; may spread to levator
Aminoglycosides — Can exacerbate myasthenia gravis
Beta-blockers (topical) — Timolol eye drops may worsen myasthenia
Statins — Rare reports of myopathy affecting eyelids
D-penicillamine — Can induce myasthenia gravis
Corticosteroids — Steroid myopathy (rare)
Neuromuscular blocking agents — Prolonged paralysis in myasthenia

Relevant Past Medical History

Diabetes mellitus — Ischemic third nerve palsy risk
Hypertension — Microvascular cranial neuropathy
Thyroid disease — Associated with myasthenia gravis; thyroid eye disease
Autoimmune conditions — Higher risk of myasthenia gravis
Previous cancer — Metastatic disease, paraneoplastic syndrome
Prior eye or eyelid surgery — Aponeurotic damage
Long-term contact lens use — Aponeurotic ptosis

Family and Social History

Family History to Explore

Ptosis in family members — Congenital ptosis, myotonic dystrophy
Muscle diseases — Muscular dystrophies, mitochondrial disorders
Autoimmune diseases — Familial clustering of myasthenia gravis
Early cataracts or cardiac problems — Myotonic dystrophy

Social and Occupational History

Smoking history — Lung cancer (Pancoast tumor causing Horner syndrome)
Occupation — Prolonged upgaze, contact lens requirements
Cosmetic procedures — Botulinum toxin, blepharoplasty
Impact on daily activities — Driving, reading, work

Focused Review of Systems

Ask specifically about:

Neurological: Diplopia, facial weakness, limb weakness, sensory changes, difficulty swallowing or speaking
Constitutional: Weight loss, fatigue, night sweats (malignancy workup)
Respiratory: Shortness of breath, voice changes (bulbar myasthenia, respiratory involvement)
Cardiovascular: Palpitations, syncope (myotonic dystrophy can cause arrhythmias)
Endocrine: Heat or cold intolerance, weight changes (thyroid disease association)

4. Physical Examination

A systematic approach to examining the patient with ptosis

Systematic Framework: Use the “Eyes First, Then Expand” approach—begin with detailed eyelid and pupil examination, then assess ocular motility, and finally perform a complete neurological examination looking for associated signs.

General Inspection

Facial symmetry: Look for facial weakness (myasthenia, myotonic dystrophy), facial asymmetry (seventh nerve palsy)
Head posture: Chin-up position suggests compensating for ptosis; head tilt may indicate fourth nerve palsy
Frontalis overaction: Raised eyebrow with forehead furrows indicates chronic ptosis with frontalis compensation
Facial features: “Hatchet face” of myotonic dystrophy, expressionless face in myasthenia
Voice quality: Nasal, slurred, or fatiguing speech suggests bulbar involvement (myasthenia)

Vital Signs

Vital Sign	What to Look For	Clinical Significance
Blood Pressure	Hypertension, asymmetric readings	Hypertension is risk factor for ischemic third nerve palsy; asymmetric BP may suggest aortic dissection extending to carotid
Heart Rate	Bradycardia, irregular rhythm	Myotonic dystrophy associated with conduction abnormalities
Respiratory Rate	Tachypnea, use of accessory muscles	May indicate impending respiratory failure in myasthenic crisis
Oxygen Saturation	Hypoxemia	Respiratory muscle weakness in myasthenia; requires urgent intervention

Detailed Eyelid Examination

Measurements

Measurement	Technique	Normal Value	Interpretation
Margin Reflex Distance 1 (MRD1)	Distance from corneal light reflex to upper lid margin in primary gaze	4-5 mm	Less than 2 mm indicates significant ptosis; negative value means lid covers pupil
Palpebral Fissure Height	Vertical distance between upper and lower lid margins	9-12 mm	Reduced in ptosis; asymmetry greater than 2 mm is significant
Levator Function	Upper lid excursion from downgaze to upgaze (block frontalis with thumb)	Greater than 12 mm	Good (greater than 12 mm), moderate (5-12 mm), poor (less than 5 mm); poor function suggests myogenic cause
Lid Crease Height	Distance from lid margin to skin crease	8-10 mm	High or absent crease suggests aponeurotic dehiscence

Special Eyelid Tests

Test	Technique	Positive Finding	Interpretation
Fatigue Test	Have patient maintain sustained upgaze for 60-120 seconds	Progressive worsening of ptosis during sustained upgaze	Highly suggestive of myasthenia gravis
Ice Pack Test	Apply ice pack to closed eyelid for 2 minutes, then reassess	Improvement of ptosis by 2 mm or more	Supports diagnosis of myasthenia gravis (cooling improves neuromuscular transmission)
Rest Test	Have patient rest with eyes closed for 30 minutes	Improvement of ptosis after rest	Supports myasthenia gravis
Cogan’s Lid Twitch	Ask patient to look down for 15 seconds, then look up quickly	Brief overshoot of upper lid followed by slow drift down	Characteristic of myasthenia gravis
Enhanced Ptosis Test	Manually elevate ptotic lid and observe contralateral lid	Contralateral lid drops when ptotic lid is elevated	Demonstrates Hering’s law; unmasks bilateral ptosis

Pupil Examination

Finding	Associated Ptosis Pattern	Diagnosis	Urgency
Dilated, fixed pupil	Complete ptosis, eye “down and out”	Compressive third nerve palsy (aneurysm)	EMERGENCY
Miosis (small pupil)	Mild ptosis (1-2 mm), upside-down ptosis (lower lid elevated)	Horner syndrome	URGENT — requires imaging to exclude carotid dissection, malignancy
Anisocoria greater in dark	Affected pupil fails to dilate	Horner syndrome (confirms sympathetic deficit)	As above
Dilation lag	Affected pupil dilates more slowly in dim light	Horner syndrome	As above
Normal, reactive pupils	Ptosis without pupil involvement	Myasthenia gravis, aponeurotic ptosis, ischemic third nerve palsy	ROUTINE — unless other concerning features

Pharmacological Pupil Testing for Horner Syndrome

If Horner syndrome is suspected, pharmacological testing can confirm and localize the lesion:

Cocaine 4-10% drops: Blocks norepinephrine reuptake. Normal pupil dilates; Horner pupil fails to dilate (confirms Horner syndrome)
Apraclonidine 0.5-1% drops: Weak alpha-1 agonist. Denervated pupil (Horner) shows reversal of anisocoria (paradoxical dilation due to denervation supersensitivity)
Hydroxyamphetamine 1% drops: Releases norepinephrine from intact postganglionic neurons. Dilation indicates first or second-order lesion; failure to dilate indicates third-order (postganglionic) lesion

Ocular Motility Examination

Finding	Pattern	Suggests
Limitation of adduction, elevation, depression	Eye “down and out” with ptosis	Complete third nerve palsy
Limitation of upgaze only	Ptosis with isolated superior rectus weakness	Superior division third nerve palsy
Variable, fatigable ophthalmoplegia	Worsens with sustained gaze, may not follow single nerve pattern	Myasthenia gravis
Symmetric limitation all directions	Bilateral, progressive, without diplopia	Chronic progressive external ophthalmoplegia
Full extraocular movements	Ptosis with normal eye movements	Aponeurotic ptosis, Horner syndrome, isolated levator involvement

Extended Cranial Nerve Examination

Trigeminal Nerve (V)

Test: Facial sensation, corneal reflex, jaw strength

Relevance: Involvement suggests cavernous sinus lesion (V1, V2 divisions)

Facial Nerve (VII)

Test: Facial symmetry, eye closure strength, forehead movement

Relevance: Weakness suggests myasthenia (fatigable), myotonic dystrophy, or brainstem lesion

Bulbar Function (IX, X, XII)

Test: Palate elevation, gag reflex, tongue movement, speech

Relevance: Bulbar weakness in myasthenia indicates higher risk of respiratory compromise

Motor Examination

Test	Technique	Abnormal Finding	Significance
Neck flexion strength	Resist head flexion against examiner’s hand	Weakness, fatigability	Weak neck flexors common in myasthenia; correlates with respiratory muscle weakness
Shoulder abduction	Arms abducted 90° for 2 minutes	Arms drift down, fatigable weakness	Proximal weakness in myasthenia; also seen in myopathies
Grip myotonia	Firm handshake, then observe hand opening	Delayed relaxation of grip	Myotonic dystrophy
Percussion myotonia	Tap thenar eminence with reflex hammer	Sustained thumb adduction and slow relaxation	Myotonic dystrophy
Counting aloud	Count from 1 to 50 continuously	Voice becomes nasal, weak, or dysarthric	Fatigable bulbar weakness in myasthenia

Expected Examination Findings by Etiology

Condition	Eyelid Findings	Pupil	Ocular Motility	Other Key Findings
Third nerve palsy (compressive)	Complete ptosis, poor levator function	Dilated, fixed	Eye “down and out”	May have headache, pain
Third nerve palsy (ischemic)	Partial or complete ptosis	Usually spared	Variable limitation	Periorbital pain, diabetic/hypertensive
Horner syndrome	Mild ptosis (1-2 mm), lower lid “upside-down ptosis”	Miosis (anisocoria worse in dark)	Normal	Anhidrosis (central/preganglionic); facial flushing
Myasthenia gravis	Variable, fatigable, bilateral asymmetric	Normal	Variable, fatigable, non-pattern	Positive fatigue test, ice test, Cogan’s lid twitch
Aponeurotic ptosis	High lid crease, good levator function	Normal	Normal	Elderly, contact lens history, thin eyelid skin
Chronic progressive external ophthalmoplegia	Bilateral, symmetric, poor levator function	Normal	Symmetric limitation all directions	No diplopia (symmetric), pigmentary retinopathy in Kearns-Sayre
Myotonic dystrophy	Bilateral ptosis, poor levator function	Normal	May have mild limitation	“Hatchet face,” frontal balding, grip myotonia, cataracts

Important Teaching Point

The examination may be entirely normal between the eyelids! In conditions like aponeurotic ptosis, Horner syndrome (except for pupil), and early myasthenia gravis, the neurological examination outside of the eyes may be completely unremarkable. A normal general examination does not exclude serious pathology. Always perform a thorough eyelid and pupil examination—the diagnosis often lies in the details of the lid and pupil findings.

Respiratory Assessment in Suspected Myasthenia Gravis

If myasthenia gravis is suspected, always assess for respiratory compromise:

Single-breath count: Ask patient to take a deep breath and count aloud; normal is greater than 25-30
Forced vital capacity (FVC): Less than 1 liter or less than 20 mL/kg is concerning
Negative inspiratory force (NIF): Weaker than -30 cm H₂O indicates risk of respiratory failure
Observe for: Use of accessory muscles, paradoxical abdominal breathing, orthopnea

The “20/30/40 Rule”: Consider ICU admission if FVC less than 20 mL/kg, NIF weaker than -30, or vital capacity decreased more than 40% from baseline.

5. Differential Diagnosis

Systematic approach organized by probability, acuity, and clinical features

Acute Ptosis (Onset: Hours to Days)

Probability	Condition	Key Features	Red Flags
MUST NOT MISS	Posterior communicating artery aneurysm	Complete ptosis, dilated fixed pupil, eye “down and out”	Severe headache, pupil involvement — neurosurgical emergency
MUST NOT MISS	Carotid artery dissection (Horner syndrome)	Mild ptosis, miosis, ipsilateral face/neck pain	Neck trauma, chiropractic manipulation, young patient with stroke symptoms
LESS COMMON (approximately 15-20%)	Ischemic third nerve palsy	Painful, pupil-sparing, diabetic/hypertensive patient	If pupil involved, must rule out aneurysm
LESS COMMON	Myasthenia gravis (new onset or crisis)	Fatigable, variable, may have diplopia or bulbar symptoms	Dysphagia, dysarthria, respiratory difficulty
RARE BUT SERIOUS	Botulism	Bilateral ptosis, descending paralysis, autonomic symptoms	Bulbar weakness, respiratory failure, contaminated food exposure
RARE BUT SERIOUS	Brainstem stroke	Ptosis with crossed signs (ipsilateral face, contralateral body)	Sudden onset, other neurological deficits
LESS COMMON	Trauma (direct or surgical)	History of injury, eyelid laceration, orbital fracture	Globe injury, orbital compartment syndrome

Chronic Ptosis (Onset: Weeks to Years)

Step-by-Step Approach to Chronic Ptosis:

Step 1: Assess the pupil — Is there miosis (Horner) or mydriasis (third nerve)?
Step 2: Test for fatigability — Does ptosis worsen with sustained upgaze? (Myasthenia gravis)
Step 3: Assess levator function — Is it good (aponeurotic) or poor (myogenic)?
Step 4: Look for associated features — Diplopia, facial weakness, systemic symptoms

Probability	Condition	Approximate Frequency	Key Distinguishing Features
COMMON	Aponeurotic (involutional) ptosis	50-60% of chronic ptosis	Elderly, high lid crease, good levator function, often bilateral, contact lens history
COMMON	Myasthenia gravis	15-20% of chronic ptosis	Fatigable, variable throughout day, bilateral asymmetric, positive ice test
LESS COMMON	Horner syndrome (chronic)	5-10%	Mild ptosis (1-2 mm), miosis, may have anhidrosis; must exclude malignancy
LESS COMMON	Chronic progressive external ophthalmoplegia	5%	Bilateral symmetric, poor levator function, ophthalmoplegia without diplopia
LESS COMMON	Myotonic dystrophy	2-5%	Bilateral, “hatchet face,” grip myotonia, frontal balding, cataracts, family history
LESS COMMON	Mechanical ptosis (dermatochalasis, tumor)	5%	Visible excess skin or mass, may have proptosis
UNCOMMON	Oculopharyngeal muscular dystrophy	Less than 2%	Late onset (50-60 years), dysphagia prominent, French-Canadian or Jewish ancestry
UNCOMMON	Kearns-Sayre syndrome	Less than 1%	Onset before age 20, pigmentary retinopathy, cardiac conduction defects

Anatomical Approach to Ptosis

Neurogenic (Neural Pathway)

Third nerve palsy (compressive/ischemic)

Horner syndrome

Marcus Gunn jaw-winking

Ophthalmoplegic migraine

Neuromuscular Junction

Myasthenia gravis

Lambert-Eaton myasthenic syndrome

Botulism

Congenital myasthenic syndromes

Myogenic (Muscle Disease)

Chronic progressive external ophthalmoplegia

Myotonic dystrophy

Oculopharyngeal muscular dystrophy

Congenital myopathies

Aponeurotic/Mechanical

Involutional (age-related)

Post-surgical

Contact lens-related

Dermatochalasis, tumors, blepharochalasis

Differential by Laterality

Primarily Unilateral

Third nerve palsy — Usually unilateral; bilateral suggests nuclear lesion
Horner syndrome — Unilateral by definition
Aponeurotic ptosis — Often asymmetric or unilateral initially
Trauma/surgical — Site-specific
Lid tumors — Usually unilateral

Primarily Bilateral

Myasthenia gravis — Bilateral but asymmetric is classic
Chronic progressive external ophthalmoplegia — Bilateral symmetric
Myotonic dystrophy — Bilateral symmetric
Oculopharyngeal muscular dystrophy — Bilateral
Botulism — Bilateral, descending paralysis

Drug-Induced Ptosis

Drug or Drug Class	Mechanism	Characteristics	Time to Resolution After Stopping
Botulinum toxin (cosmetic or therapeutic)	Blocks acetylcholine release at neuromuscular junction; may spread to levator	Unilateral, dose-related, occurs 1-2 weeks after injection	2-4 months (as toxin effect wears off)
Aminoglycosides	Impair neuromuscular transmission; can unmask or exacerbate myasthenia	May precipitate myasthenic crisis in susceptible patients	Days to weeks after discontinuation
Beta-blockers (topical timolol)	May worsen myasthenia gravis; possible direct effect on levator	Usually bilateral, worsens existing ptosis	Days to weeks
D-penicillamine	Induces autoimmune myasthenia gravis (anti-AChR antibodies)	True myasthenia syndrome; fatigable weakness	Months; may persist after drug discontinuation
Statins	Myopathy; rare reports of ptosis	May be associated with generalized myopathy	Weeks to months
Corticosteroids (chronic)	Steroid myopathy affecting levator	Usually with other features of steroid myopathy	Months after dose reduction
Chloroquine/Hydroxychloroquine	Neuromyopathy with chronic use	May be associated with proximal weakness	May be irreversible

Quick Reference: “If You See This, Think This”

Clinical Clue	Think This First	Next Step
Ptosis + dilated pupil + “down and out” eye	Compressive third nerve palsy (aneurysm)	Emergent CT angiography or MR angiography
Ptosis + miosis + anhidrosis	Horner syndrome	Imaging of sympathetic chain (brain, neck, chest)
Ptosis worse at end of day, improves with rest	Myasthenia gravis	Ice test, acetylcholine receptor antibodies, repetitive nerve stimulation
Ptosis + high lid crease + elderly patient	Aponeurotic (involutional) ptosis	Ophthalmology referral for surgical evaluation
Bilateral ptosis + ophthalmoplegia + no diplopia	Chronic progressive external ophthalmoplegia	Muscle biopsy, mitochondrial DNA testing, cardiac evaluation
Ptosis + grip myotonia + “hatchet face”	Myotonic dystrophy	Genetic testing (DMPK gene), cardiac evaluation (ECG, Holter)
Ptosis + dysphagia + late onset	Oculopharyngeal muscular dystrophy	Genetic testing (PABPN1 gene)
Ptosis after recent botulinum toxin injection	Iatrogenic (toxin spread to levator)	Reassurance; will resolve in 2-4 months
Acute bilateral ptosis + descending paralysis	Botulism	ICU admission, antitoxin, supportive care
Ptosis with jaw movement (chewing elevates lid)	Marcus Gunn jaw-winking phenomenon	Usually congenital; observe if mild

Pseudoptosis: Conditions That Mimic Ptosis

Before diagnosing true ptosis, exclude these mimics:

Dermatochalasis: Excess upper eyelid skin that hangs over the lid margin — lift the skin to reveal normal lid position
Brow ptosis: Drooping of the eyebrow creates appearance of eyelid drooping — assess brow position
Contralateral lid retraction: The normal eye appears ptotic compared to a retracted lid (thyroid eye disease) — measure both MRD1 values
Hypotropia: Eye is deviated downward, creating illusion of ptosis — perform cover test
Enophthalmos: Sunken eye makes lid appear droopy — assess globe position
Phthisis bulbi: Shrunken eye with apparent ptosis — examine globe

6. Diagnostic Investigations

A stepwise, cost-effective approach guided by clinical suspicion

Baseline Investigations for All Patients with Unexplained Ptosis

Investigation	Purpose	What to Look For	Practical Points
Complete blood count	General screening, infection, malignancy	Anemia (chronic disease), lymphocytosis (thymoma association)	Not specific but part of general workup
Thyroid function tests	Thyroid disease often coexists with myasthenia gravis	Hyper- or hypothyroidism; thyroid eye disease can cause lid retraction or restriction	Up to 10% of myasthenia gravis patients have thyroid disease
Fasting glucose / HbA1c	Diabetes is major risk factor for ischemic cranial neuropathy	Undiagnosed diabetes mellitus	Important in suspected ischemic third nerve palsy
Acetylcholine receptor (AChR) antibodies	Diagnose myasthenia gravis	Positive in 85% of generalized myasthenia gravis, 50% of ocular myasthenia	Order in all unexplained ptosis with fatigability; false negatives common in ocular myasthenia

Targeted Investigations by Suspected Etiology

If Suspecting Myasthenia Gravis

First-Line Tests

Ice pack test: Apply ice to closed lid for 2 minutes; improvement of 2 mm or more supports myasthenia (sensitivity 80-90%)
AChR binding antibodies: Positive in 85% generalized, 50% ocular myasthenia gravis
AChR modulating antibodies: May add sensitivity when binding antibodies negative

Second-Line Tests

Anti-MuSK antibodies: Order if AChR negative; positive in 40% of seronegative myasthenia gravis
Anti-LRP4 antibodies: Newer marker; consider if AChR and MuSK negative
Repetitive nerve stimulation: Greater than 10% decrement is positive; sensitivity 75% generalized, 30-50% ocular
Single-fiber electromyography: Most sensitive test (95%); increased jitter and blocking
CT chest: All confirmed myasthenia gravis patients need chest imaging to evaluate for thymoma (10-15%)

If Suspecting Third Nerve Palsy

Pupil-Involving (Emergency)

CT angiography (CTA) of head: First-line; rapid, widely available; sensitivity greater than 95% for aneurysms greater than 3 mm
MR angiography (MRA): Alternative if CT contraindicated; no radiation
Conventional angiography: Gold standard if CTA/MRA negative but high clinical suspicion
MRI brain with contrast: Evaluate for other compressive lesions, cavernous sinus pathology

Pupil-Sparing (Presumed Ischemic)

MRI brain: Rule out structural lesion if atypical features
Vascular risk factor assessment: HbA1c, lipid profile, blood pressure
Consider CTA/MRA: If patient younger than 50, no vascular risk factors, or any pupil involvement
ESR, CRP: In older patients to screen for giant cell arteritis

Critical Decision Point: Pupil-Involving Third Nerve Palsy

Any third nerve palsy with pupil involvement (dilated, poorly reactive pupil) requires emergent vascular imaging to exclude posterior communicating artery aneurysm. Do not delay imaging for any reason. Even “partial” pupil involvement (anisocoria greater than 1 mm with sluggish reaction) warrants urgent evaluation.

If Suspecting Horner Syndrome

Confirm Diagnosis

Apraclonidine 0.5-1% test: Reversal of anisocoria (Horner pupil dilates more than normal) confirms diagnosis
Cocaine 4-10% test: Failure of Horner pupil to dilate confirms diagnosis (cocaine blocks norepinephrine reuptake)

Localize and Image

Hydroxyamphetamine test: Differentiates preganglionic (dilates) from postganglionic (no dilation) lesions
MRI/MRA brain and neck: First-order lesions (brainstem)
CT chest: Second-order lesions (Pancoast tumor)
CTA/MRA neck: Carotid dissection (postganglionic); urgent if acute onset with pain

Horner Syndrome Imaging Protocol:

Acute painful Horner: CTA or MRA neck immediately to rule out carotid dissection
Chronic Horner: MRI brain (brainstem), CT chest (Pancoast tumor), MRA neck (carotid)
Imaging should cover entire sympathetic pathway: Hypothalamus → brainstem → cervical cord → lung apex → neck → orbit

If Suspecting Mitochondrial Myopathy (Chronic Progressive External Ophthalmoplegia)

First-Line Tests

Serum lactate: May be elevated at rest or after exercise
Creatine kinase: Often normal or mildly elevated
ECG: Cardiac conduction defects (especially in Kearns-Sayre syndrome)

Confirmatory Tests

Muscle biopsy: Ragged red fibers on Gomori trichrome stain; cytochrome oxidase-negative fibers
Mitochondrial DNA analysis: Single large-scale deletions (common); point mutations
Dilated fundus examination: Pigmentary retinopathy in Kearns-Sayre syndrome
Echocardiogram: Cardiomyopathy screening

If Suspecting Myotonic Dystrophy

Diagnostic Tests

Genetic testing: CTG repeat expansion in DMPK gene (type 1); CCTG expansion in CNBP gene (type 2)
Electromyography: Myotonic discharges (“dive bomber” sound)
Slit-lamp examination: Characteristic “Christmas tree” cataracts

Systemic Screening

ECG and Holter monitor: Conduction defects, arrhythmias (sudden death risk)
Pulmonary function tests: Respiratory muscle weakness
Fasting glucose: Insulin resistance common
Liver function tests: Elevated GGT common

Diagnostic Trials and Bedside Tests

Bedside Diagnostic Tests for Myasthenia Gravis

When laboratory testing is pending or antibodies are negative, bedside tests can support the diagnosis:

Ice pack test: Apply ice to closed eyelid for 2 minutes. Improvement of ptosis by 2 mm or more is positive (sensitivity 80-90%, specificity 97%)
Rest test: Have patient rest with eyes closed for 30 minutes. Improvement supports myasthenia gravis
Sleep test: Photograph before and after 30-minute nap; compare ptosis severity
Edrophonium (Tensilon) test: Rarely used now due to cardiac risks; requires atropine on hand; improvement within 1-2 minutes supports diagnosis

Investigation Algorithm by Clinical Scenario

Clinical Scenario	Immediate Investigation	Additional Workup
Ptosis + dilated pupil + headache	Emergent CTA head	Conventional angiography if CTA negative; neurosurgical consultation
Ptosis + miosis + neck/face pain	Urgent CTA/MRA neck	If negative, complete Horner workup (brain MRI, chest CT)
Fatigable ptosis, variable diplopia	AChR antibodies, ice pack test	If seronegative: anti-MuSK, repetitive nerve stimulation, single-fiber EMG; CT chest for thymoma
Bilateral ptosis + ophthalmoplegia + no diplopia	Serum lactate, CK, ECG	Muscle biopsy, mitochondrial DNA analysis, cardiac evaluation
Ptosis + myotonia + family history	Genetic testing for myotonic dystrophy	ECG, Holter monitor, slit-lamp examination, pulmonary function tests
Elderly + high lid crease + good levator function	Clinical diagnosis of aponeurotic ptosis	Ophthalmology referral for surgical evaluation; exclude myasthenia if any fatigability
Pupil-sparing third nerve palsy + vascular risk factors	MRI brain, vascular risk assessment	Observe for 3 months for recovery; image if atypical or no improvement

When to Refer for Specialist Evaluation

Neurology (Urgent)

Any pupil-involving third nerve palsy
Suspected myasthenia gravis with bulbar or respiratory symptoms
Acute Horner syndrome
Ptosis with other neurological deficits

Neuro-Ophthalmology

Unexplained ptosis after initial workup
Seronegative suspected myasthenia
Chronic progressive external ophthalmoplegia
Complex diplopia evaluation

Oculoplastics

Aponeurotic ptosis for surgical repair
Mechanical ptosis (dermatochalasis, tumor)
Congenital ptosis
Post-surgical ptosis

7. Pattern Recognition and Clinical Decision-Making

Practical algorithms and decision pathways for ptosis evaluation

Step 1: Is This Urgent?

Clinical Scenario	Urgency Level	Immediate Action
Ptosis + dilated pupil + headache	EMERGENT	Immediate CTA head; neurosurgical consultation; do not delay for any reason
Ptosis + diplopia + complete ophthalmoplegia	EMERGENT	Urgent vascular imaging even if pupil “spared”; close observation for pupil changes
Ptosis + dysphagia + respiratory difficulty	EMERGENT	Myasthenic crisis until proven otherwise; check FVC, NIF; ICU admission if respiratory compromise
Acute Horner syndrome + neck/face pain	URGENT	Same-day CTA/MRA neck to exclude carotid dissection
Ptosis + fatigability + bulbar symptoms	URGENT	Expedited myasthenia workup; assess respiratory function; neurology referral within days
New Horner syndrome without pain	URGENT	Imaging within 1-2 weeks to exclude Pancoast tumor or other malignancy
Chronic progressive ptosis, elderly, high lid crease	ROUTINE	Outpatient ophthalmology/oculoplastics referral; exclude myasthenia if any variability
Long-standing bilateral ptosis, no diplopia	ROUTINE	Elective workup for chronic progressive external ophthalmoplegia or muscular dystrophy

Step 2: Initial Assessment Algorithm

The “PUPILS First” Approach: Always begin by examining the pupils—this single finding determines your entire pathway.

Dilated Pupil

Diagnosis: Third nerve palsy (compressive)

Action: Emergent CTA → neurosurgery

Do not: Wait, observe, or delay imaging

Constricted Pupil (Miosis)

Diagnosis: Horner syndrome

Action: Confirm with pharmacological testing → image sympathetic pathway

Priority: Urgent if acute/painful; soon if chronic

Normal Pupils

Possibilities: Myasthenia, aponeurotic, ischemic third nerve palsy

Action: Proceed to fatigability testing

Next step: Ice test, sustained upgaze test

Step 3: Assess Fatigability (If Pupils Normal)

Test Result	Interpretation	Next Step
Positive fatigue test (ptosis worsens with sustained upgaze)	Highly suggestive of myasthenia gravis	Ice test → AChR antibodies → repetitive nerve stimulation if seronegative
Positive ice test (improvement ≥2 mm)	Supports myasthenia gravis (sensitivity 80-90%)	Confirm with antibody testing; CT chest for thymoma
Negative fatigue test, good levator function	Likely aponeurotic ptosis	Assess lid crease height; ophthalmology referral for surgical evaluation
Negative fatigue test, poor levator function	Consider myogenic cause (chronic progressive external ophthalmoplegia, muscular dystrophy)	Check for ophthalmoplegia; consider muscle biopsy, genetic testing
Variable results, symptoms fluctuate	Still consider myasthenia gravis (can have normal exam at times)	Repeat testing when symptomatic; serology; EMG studies

Step 4: Third Nerve Palsy Decision Pathway

Clinical Features	Most Likely Etiology	Investigation	Management
Pupil-involving + any age	Compressive (aneurysm until proven otherwise)	Emergent CTA; if negative, MRA or conventional angiography	Neurosurgical consultation; endovascular or surgical treatment
Pupil-sparing + age >50 + vascular risk factors	Ischemic (microvascular)	MRI brain; vascular risk factor assessment; consider CTA if atypical	Risk factor modification; expect recovery in 2-3 months; re-image if no improvement
Pupil-sparing + age <50 + no risk factors	Must exclude compressive lesion	CTA or MRA head regardless of pupil status	Based on imaging findings; close follow-up if negative
Partial pupil involvement (anisocoria 1-2 mm)	Treat as compressive until proven otherwise	Emergent CTA; do not rely on “relative” pupil sparing	As per compressive etiology
Third nerve palsy + other cranial nerves	Cavernous sinus lesion, brainstem pathology	MRI brain with contrast; MRA; consider lumbar puncture	Based on etiology (tumor, inflammation, infection)

Step 5: Myasthenia Gravis Management Decisions

Clinical Situation	Severity Assessment	Management Approach
Ocular symptoms only (ptosis, diplopia)	Ocular myasthenia gravis (Class I)	Pyridostigmine; consider low-dose prednisone if refractory; monitor for generalization
Mild generalized weakness + ocular	Mild generalized (Class II)	Pyridostigmine + immunotherapy (prednisone, steroid-sparing agents); CT chest for thymoma
Bulbar symptoms (dysphagia, dysarthria)	Moderate-severe (Class III-IV)	Aggressive immunotherapy; consider IVIG or plasmapheresis; close monitoring for crisis
Respiratory symptoms or FVC <20 mL/kg	Myasthenic crisis (Class V)	ICU admission; intubation if needed; plasmapheresis or IVIG; hold pyridostigmine

“What Do I Do If…” Decision Reference

Clinical Situation	Immediate Action	Next Step
Patient presents with acute ptosis and severe headache	Assess pupil immediately; if dilated or sluggish, emergent CTA	Neurosurgical consultation; do not discharge without vascular imaging
AChR antibodies are negative but I still suspect myasthenia	Order anti-MuSK antibodies; perform ice test and fatigue testing	Repetitive nerve stimulation; single-fiber EMG if still negative; consider seronegative myasthenia
Patient with known myasthenia develops worsening ptosis	Assess for myasthenic crisis vs cholinergic crisis; check respiratory function	If FVC declining, admit to ICU; if stable, adjust medications and close follow-up
Elderly patient with “simple” ptosis wants surgery	Ensure myasthenia has been excluded (fatigability testing, consider antibodies)	Perform enhanced ptosis test to unmask contralateral ptosis before referring to oculoplastics
Horner syndrome confirmed but initial imaging negative	Ensure entire sympathetic pathway was imaged (brain to chest)	Repeat imaging in 3-6 months; some lesions (especially Pancoast tumors) may be occult initially
Pupil-sparing third nerve palsy not improving at 3 months	Re-image with MRI/MRA to exclude slowly growing lesion	Consider alternative diagnoses; neuro-ophthalmology referral
Patient develops ptosis after botulinum toxin injection	Reassure patient—this is temporary (toxin spread to levator)	Supportive care; apraclonidine drops may provide temporary improvement; resolves in 2-4 months
Bilateral symmetric ptosis with ophthalmoplegia but no diplopia	Consider chronic progressive external ophthalmoplegia	ECG (cardiac conduction defects); fundoscopy (pigmentary retinopathy); refer for muscle biopsy

Troubleshooting Refractory or Unexplained Ptosis

Ask These Questions When Ptosis Remains Unexplained

Have I truly excluded myasthenia? (Seronegative myasthenia is common in ocular disease—consider single-fiber EMG)
Did I examine the patient when symptomatic? (Myasthenia can be normal between episodes)
Have I checked for bilateral involvement? (Perform enhanced ptosis test to unmask contralateral side)
Did I look carefully at the pupil in different lighting? (Subtle Horner syndrome may be missed)
Have I considered drug-induced causes? (Review all medications, including eye drops)
Could this be pseudoptosis? (Dermatochalasis, brow ptosis, contralateral lid retraction)
Is the patient reliable historian? (Ask family about variability, old photographs)
Should I repeat imaging? (Some lesions grow slowly or were initially occult)

8. Clinical Pearls and Pitfalls

Practical wisdom — learn from successes and avoid common mistakes

Must-Know Clinical Pearls

The pupil tells the story: In acute third nerve palsy, a dilated pupil means compression (aneurysm) until proven otherwise, while a spared pupil suggests ischemia. This single finding determines the urgency of your entire workup.

Ice is your friend: The ice pack test is free, fast, and has excellent sensitivity (80-90%) and specificity (97%) for myasthenia gravis. Use it liberally—it can provide immediate diagnostic support while awaiting antibody results.

Always check for bilateral disease: Use the enhanced ptosis test (manually elevate the ptotic lid and watch the other eye drop) to unmask bilateral ptosis before surgical planning. Missing this causes postoperative dissatisfaction.

Myasthenia is the great imitator: Ocular myasthenia can mimic almost any pattern of ocular motility disorder. If the pattern “doesn’t fit” a single cranial nerve, think myasthenia gravis.

Seronegative doesn’t mean no myasthenia: Up to 50% of patients with purely ocular myasthenia gravis are AChR antibody-negative. If clinical suspicion is high, proceed with anti-MuSK testing and electrodiagnostics.

Horner syndrome requires complete imaging: The sympathetic pathway spans from hypothalamus to orbit. Imaging must include brain MRI, CT chest (Pancoast tumor), and neck vessels (carotid dissection). Incomplete imaging misses life-threatening diagnoses.

No diplopia with ophthalmoplegia = chronic progressive external ophthalmoplegia: When eye movements are restricted bilaterally but the patient doesn’t complain of double vision, suspect mitochondrial disease. The brain adapts to symmetric, slowly progressive limitation.

Old photographs are diagnostic gold: Ask to see old photos (driver’s license, wedding photos). They can reveal whether ptosis is truly new or longstanding, and whether it has progressed.

Critical Pitfalls to Avoid

Trusting “pupil-sparing” too much: A pupil-sparing third nerve palsy in a young patient without vascular risk factors still needs vascular imaging. Additionally, partial pupil involvement (subtle anisocoria) can be missed—examine in bright and dim light.

Assuming all elderly ptosis is “just aging”: While aponeurotic ptosis is common in the elderly, myasthenia gravis has a second peak in the 60s-70s. Always test for fatigability before attributing ptosis to aging alone.

Forgetting to block the frontalis: When measuring levator function, failure to immobilize the brow leads to falsely elevated measurements. Press your thumb firmly on the brow during the test.

Dismissing a “painless” Horner as benign: While cluster headache causes painful Horner syndrome, Pancoast tumors and other malignancies often cause painless Horner. All new Horner syndromes require imaging regardless of pain.

Stopping workup after negative AChR antibodies: Seronegative myasthenia is common in ocular disease. A negative AChR antibody test should prompt anti-MuSK testing and consideration of electrodiagnostic studies, not closure of the case.

Examining only when the patient feels “fine”: Myasthenia symptoms fluctuate. If initial examination is normal but history is suggestive, have the patient return when symptomatic, or perform prolonged fatigue testing.

Missing respiratory compromise in myasthenia: Ptosis can be the tip of the iceberg. Always assess respiratory function (single-breath count, FVC) in suspected or known myasthenia. Respiratory failure can develop rapidly.

Incomplete Horner syndrome imaging: Imaging only the brain or only the neck misses lesions at other levels. The entire sympathetic pathway must be visualized—from brainstem to orbit, including lung apex.

Key Takeaways

Ptosis evaluation begins and ends with the pupil—dilated suggests compressive third nerve palsy (emergency), constricted suggests Horner syndrome, and normal suggests myasthenia or aponeurotic causes.
Any third nerve palsy with pupil involvement requires emergent vascular imaging to exclude posterior communicating artery aneurysm—do not delay for any reason.
Myasthenia gravis is the most important treatable cause of ptosis; always test for fatigability (sustained upgaze test, ice test) in unexplained ptosis.
Seronegative myasthenia gravis is common (up to 50% in ocular myasthenia)—negative AChR antibodies do not exclude the diagnosis; order anti-MuSK and consider electrodiagnostics.
Horner syndrome requires imaging of the entire sympathetic pathway (brain, neck, chest) to exclude carotid dissection, Pancoast tumor, and other serious pathology.
Aponeurotic ptosis is the most common cause in elderly patients but is a diagnosis of exclusion—always rule out myasthenia gravis first.
Use the enhanced ptosis test before surgical referral to unmask contralateral ptosis and avoid postoperative disappointment.
Bilateral symmetric ptosis with ophthalmoplegia but without diplopia suggests chronic progressive external ophthalmoplegia—screen for associated cardiac disease.
In myasthenia gravis, always assess respiratory function—bulbar and respiratory involvement can develop rapidly and become life-threatening.
When the diagnosis remains elusive, review the medication list (especially recent botulinum toxin), request old photographs, and consider repeating the examination when the patient is symptomatic.

Quick Reference Algorithm

Systematic Approach to Ptosis:

Examine the pupil first — Dilated (third nerve compression → emergent imaging), Constricted (Horner syndrome → image sympathetic pathway), Normal (proceed to step 2)
Test for fatigability — Sustained upgaze for 60-120 seconds; perform ice test if available
Measure levator function — Good function (greater than 12 mm) suggests aponeurotic; poor function (less than 5 mm) suggests myogenic cause
Assess for associated features — Diplopia (third nerve, myasthenia), bulbar symptoms (myasthenia), myotonia (myotonic dystrophy)
Order targeted investigations — Based on clinical suspicion: AChR antibodies for myasthenia; CTA for third nerve palsy; imaging of sympathetic pathway for Horner
Refer appropriately — Neurology for unexplained neurogenic ptosis; neuro-ophthalmology for complex cases; oculoplastics for aponeurotic ptosis surgical repair